Alinaya Rosabel Realica

Avg. Two Year Performance

No purchase track record

66% Avg. Sale Return

29% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	8%	42%	40%	77%	66%
Sale Success Rate	1 of 1	1 of 1	1 of 1	1 of 1	1 of 1

MannKind Corp.

Drugs » Biotechnology

VP, IR & Treasury:

Holdings: 167.12K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--